Authors:
EVANS WK
EARLE CC
STEWART DJ
DAHROUGE S
TOMIAK E
GOSS G
LOGAN D
GOEL R
GERTLER SZ
DULUDE H
Citation: Wk. Evans et al., PHASE-II STUDY OF A ONE-HOUR PACLITAXEL INFUSION IN COMBINATION WITH CARBOPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 18(1), 1997, pp. 83-94
Authors:
BARDY P
CONNEALLY E
EMERMAN JT
LANSDORP PM
GOSS G
HUMPHRIES RK
EAVES CJ
Citation: P. Bardy et al., ISOLATION AND ANALYSIS OF DIFFERENT SUBPOPULATIONS OF NORMAL HUMAN BREAST EPITHELIAL-CELLS EARLY AFTER THEIR INFECTION WITH A RETROVIRAL VECTOR ENCODING A CELL-SURFACE MARKER, Breast cancer research and treatment, 44(2), 1997, pp. 153-165
Citation: G. Goss, CLINICAL LABORATORY IMPROVEMENT ACT OF 1988 - BACKGROUND AND IMPACT ON ANATOMIC LABORATORIES, Journal of histotechnology, 20(2), 1997, pp. 159-162
Authors:
SHEPHERD FA
CORMIER Y
BURKES R
EVANS WK
GOSS G
KLIMO P
FELD R
TAYLOR M
Citation: Fa. Shepherd et al., PHASE-II TRIAL OF GEMCITABINE AND WEEKLY CISPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 827-830
Citation: G. Goss et al., MULTIPLE CYCLES OF AGGRESSIVE CHEMOTHERAPY PRIOR TO AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION FOR LYMPHOMA, Australian and New Zealand Journal of Medicine, 27(3), 1997, pp. 323-329
Citation: G. Goss et al., COIMMUNOPRECIPITATION OF A 24-KDA PROTEIN WITH NHE1, THE UBIQUITOUS ISOFORM OF THE NA+ H+ EXCHANGER/, American journal of physiology. Cell physiology, 39(5), 1996, pp. 1493-1502
Citation: G. Goss et al., INTERMEDIATE-DOSE CYCLOPHOSPHAMIDE COMBINED WITH A GROWTH-FACTOR IS ASAFE AND EFFECTIVE REGIMEN FOR MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS, Australian and New Zealand Journal of Medicine, 26(3), 1996, pp. 411-413
Citation: Ld. Shrode et al., CHYMOTRYPSIN REMOVES THE N-TERMINAL DOMAIN OF THE NA+ H+ EXCHANGER BUT DOES NOT AFFECT ITS FUNCTION/, Molecular biology of the cell, 6, 1995, pp. 336-336
Authors:
LOCHRIN C
GOSS G
CROSS P
STEWART D
TOMIAK E
AGBOOLA O
AREF I
REID K
GIRARD A
LOGAN D
CREPEAU A
DAHROUGE S
EVANS WK
Citation: C. Lochrin et al., CONCURRENT DAILY CHEMOTHERAPY WITH HYPERFRACTIONATED THORACIC IRRADIATION IN STAGE IIIA-AND-B NSCLC, European journal of cancer, 31A, 1995, pp. 1100-1100
Authors:
KAUL S
IGWEMEZIE LN
STEWART DJ
FIELDS SZ
KOSTY M
LEVITHAN N
BUKOWSKI R
GANDARA D
GOSS G
ODWYER P
SCHACTER LP
BARBHAIYA RH
Citation: S. Kaul et al., PHARMACOKINETICS AND BIOEQUIVALENCE OF ETOPOSIDE FOLLOWING INTRAVENOUS ADMINISTRATION OF ETOPOSIDE PHOSPHATE AND ETOPOSIDE IN PATIENTS WITHSOLID TUMORS, Journal of clinical oncology, 13(11), 1995, pp. 2835-2841
Authors:
EVANS WK
RADWI A
TOMIAK E
LOGAN DM
MARTINS H
STEWART DJ
GOSS G
MAROUN JA
DAHROUGE S
Citation: Wk. Evans et al., ORAL ETOPOSIDE AND CARBOPLATIN - EFFECTIVE THERAPY FOR ELDERLY PATIENTS WITH SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 18(2), 1995, pp. 149-155
Authors:
LATREILLE J
CORMIER Y
MARTINS H
GOSS G
FISHER B
EISENHAUER EA
Citation: J. Latreille et al., PHASE-II STUDY OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH PREVIOUSLY UNTREATED EXTENSIVE SMALL-CELL LUNG-CANCER - A TRIAL OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP (NCIC CTG), Investigational new drugs, 13(4), 1995, pp. 343-345
Authors:
GOSS G
MULDAL A
LOHMANN R
TAYLOR M
LOPEZ P
ARMITAGE G
STEWARD WP
Citation: G. Goss et al., DIDEMNIN-B IN FAVORABLE HISTOLOGY NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Investigational new drugs, 13(3), 1995, pp. 257-260
Authors:
EVANS WK
STEWART DJ
SHEPHERD FA
LOGAN D
GOSS G
MAROUN JA
WIERZBICKI R
WARNER E
LATREILLE J
DAHROUGE S
Citation: Wk. Evans et al., VP-16, IFOSFAMIDE AND CISPLATIN (VIP) FOR EXTENSIVE SMALL-CELL LUNG-CANCER, European journal of cancer, 30A(3), 1994, pp. 299-303
Authors:
CORMIER Y
EISENHAUER E
MULDAL A
GREGG R
AYOUB J
GOSS G
STEWART D
TARASOFF P
WONG D
Citation: Y. Cormier et al., GEMCITABINE IS AN ACTIVE NEW AGENT IN PREVIOUSLY UNTREATED EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP, Annals of oncology, 5(3), 1994, pp. 283-285
Authors:
VINCENT M
GOSS G
SINOFF C
GERMOND C
BOZEK T
HELIE G
KOSKI T
CORRINGHAM S
CORRINGHAM R
Citation: M. Vincent et al., BIWEEKLY VINCRISTINE, EPIRUBICIN AND METHYLPREDNISOLONE IN ALKYLATOR-REFRACTORY MULTIPLE-MYELOMA, Cancer chemotherapy and pharmacology, 34(4), 1994, pp. 356-360
Citation: A. Grigg et al., PHASE-I DOSE-ESCALATION STUDY OF 5 DAYS CONTINUOUS-INFUSION (CL) VP16PLUS BUSULFAN-CYCLOPHOSPHAMIDE (BU-CY) AS A CONDITIONING REGIMEN PRIOR TO AUTOLOGOUS TRANSPLANTATION (TP), Blood, 84(10), 1994, pp. 10000210-10000210
Citation: A. Grigg et al., FAILURE OF ENGRAFTMENT OF LENOGRASTIM MOBILIZED ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS IN APLASTIC-ANEMIA, Australian and New Zealand Journal of Medicine, 24(6), 1994, pp. 736-737
Authors:
GERMOND C
YAU J
GOSS G
GLUCK S
CRIPPS C
VERMA S
SINOFF C
DORREEN M
Citation: C. Germond et al., TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMA IN THE ELDERLY WITH MITOXANTRONE, PREDNIMUSTINE AND VINCRISTINE (NSO), Blood, 82(10), 1993, pp. 10000564-10000564